CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

TwoStep Therapeutics raises $62.5m in funding to advance TS-104

TS-104Positive
AI Analysis

Summary

TwoStep Therapeutics raised $62.5m in Series A financing to advance TS-104, a peptide-drug conjugate candidate for solid tumours.

Importance:5/10
Sentiment:
0.60
fundingSeries Apeptide-drug conjugateoncology
Related Companies

Read the original article

Published by Pharmaceutical Technology on September 10, 2026 8:14 AM

Read Original